Peripheral kappa opioid receptors activation reduces alveolar bone loss in rats by modulating interleukin-6 and -10

Archives of Oral Biology

Volumn 56, Issue 6, 2011, Pages 540-548

  Bastos, Jasílio Vilela ^a   Queiroz Junior, Celso Martins ^a   Caliari, Marcelo Vidigal ^a   Francischi, Janetti Nogueira ^a   Pacheco, Cinthia Mara Da Fonseca ^b,c   Maltos, Kátia Lucy De Melo ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b CENTRO UNIVERSITÁRIO NEWTON PAIVA   (Brazil)

^c NONE   (Brazil)

Author keywords

Alveolar bone loss; IL 10; IL 6; Opioids

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; KAPPA OPIATE RECEPTOR; PEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; MALE; OSTEOCLAST; RAT; SPRAGUE DAWLEY RAT;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; OSTEOCLASTS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 79956204788     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2010.11.012     Document Type: Article

References (41)

1. R.C. Page, S. Offenbacher, H.E. Schroeder, G.J. Seymour, and K.S. Kornman Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions Periodontol 2000 14 1997 216 248 (Pubitemid 127601178)
2. K.S. Kornman Mapping the pathogenesis of periodontitis: a new look Periodontol 2000 79 2008 1560 1568
3. C.M.F. Pacheco, C.M. Queiroz-Junior, K.L.M. Maltos, M.V. Caliari, O.A. Rocha, and J.N. Francischi Local opioids in a model of periodontal disease in rats Arch Oral Biol 52 2007 677 683 (Pubitemid 46691299)
4. C.M.F. Pacheco, C.M. Queiroz-Junior, K.L.M. Maltos, M.V. Caliari, D.F. Pacheco, and I.D.G. Duarte Crucial role of peripheral κ-opioid receptors in a model of periodontal disease in rats J Periodontol Res 43 2008 730 736
5. L.R. Flores, S.M. Wahl, and B.M. Bayer Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking J Pharmacol Exp Ther 272 1995 1246 1251
6. M.C. Grimm, A. Ben-Baruch, D.D. Taub, O.M. Howord, J.M. Wang, and J.J. Oppenheim Opiate inhibition of chemokine-induced chemotaxis Ann N Y Acad Sci 840 1998 9 20 (Pubitemid 28302032)
7. Z. Pourpak, A. Ahmadiani, and M. Alebouyeh Involvement of interleukin-1β in systemic morphine effects on paw oedema in a mouse model of acute inflammation Scand J Immunol 59 2004 273 277
8. Y. Rao, Y. Wang, J. Li, and J. Ke Effects of morphine and fentanyl on tumor necrosis factor-α and interleukin-6 concentrations in human blood in vitro Chin Med J 117 2004 303 304 (Pubitemid 38351464)
9. 2 and periodontal status in a community population J Clin Periodontol 34 2007 285 293
10. J. Gamonal, A. Acevedo, A. Bascones, O. Jorge, and A. Silva Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis J Periodontol Res 36 2001 194 203 (Pubitemid 33643505)
11. I. Ikezawa, H. Tai, Y. Shimada, Y. Komatsu, J.C. Galicia, and H. Yoshie Imbalance between soluble tumor necrosis factor receptors type 1 and 2 in chronic periodontitis J Clin Periodontol 32 2005 1047 1054 (Pubitemid 41391078)
12. A.J. Delima, S. Karatzas, S. Amar, and D.T. Graves Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists J Infect Dis 186 2002 511 516 (Pubitemid 34876260)
13. T.W. Oates, D.T. Graves, and D.L. Cochran Clinical, radiographic and biochemical assessment of IL-1/TNF-α antagonist inhibition of bone loss in experimental periodontitis J Clin Periodontol 29 2002 137 143 (Pubitemid 41697746)
14. P.J. Baker, M. Dixon, R.T. Evans, L. Dufour, E. Johnson, and D.C. Roopenian CD4+ T cells and the pro-inflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice Infect Immun 67 1999 2804 2809 (Pubitemid 29244693)
15. M.A. Cassatella, L. Leda, S. Bonora, M. Ceska, and G. Constantin Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide J Exp Med 178 1993 2207 2211 (Pubitemid 23344879)
16. M. Puliti, C. Von Hunolstein, C. Verwarde, F. Bistoni, G. Orefici, and L. Tissi Regulatory role of interleukin-10 in experimental group B streptococcal arthritis Infect Immun 70 2002 2862 2868 (Pubitemid 34564142)
17. G.P. Garlet, C.R. Cardoso, T.A. Silva, B.R. Ferreira, M.J. Ávila-Campos, and F.Q. Cunha Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors Oral Microbiol Immunol 21 2006 12 20
18. K. Sallay, F. Sanavi, I. Ring, P. Pham, U.H. Behling, and A. Nowotny Alveolar bone destruction in the immunosuppressed rat J Periodontol Res 17 1982 263 274 (Pubitemid 13228052)
19. P. Sacerdote Opioid-induced immunosuppression Palliat Med 2 2008 14 18
20. P.P. Bradley, D.A. Priebat, R.D. Christensen, and G. Rothstein Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J Invest Dermatol 78 1982 206 209 (Pubitemid 12171880)
21. C.M. Queiroz-Junior, C.M.F. Pacheco, A.H. Fonseca, A. Klein, M.V. Caliari, and J.N. Francischi Myeloperoxidase content is a marker of systemic inflammation in a chronic condition: the example given by the periodontal disease in rats Mediat Inflam 2009 2009 1 7 Article ID: 760837
22. T.E. Van Dyke, and C.N. Serhan Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases J Dent Res 82 2003 82 90 (Pubitemid 41764116)
23. A. Bascones-Martínez, M. Muñoz, S. Noronha, P. Mota, C. Bascones-Ilundain, and J. Campo Host defense mechanisms against bacterial aggression in periodontal disease: basic mechanisms Med Oral Patol Oral Cirur Bucal 14 2009 e680 e685
24. J.M. Bidlack Detection and function of opioid receptors on cells from the immune system Clin Diagn Lab Immunol 5 2000 719 723
25. T. Myagi, L.F. Chuang, K.M. Lam, H. Kung, J.M. Wang, and B.I. Osburn Opioid suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response Immunopharmacology 47 2000 53 62 (Pubitemid 30120024)
26. A. Kulkarni-Narla, B. Walcheck, and D.R. Brown Opioid receptors on bone marrow neutrophils modulate chemotaxis and CB11b/CD18 expression Eur J Pharmacol 414 2001 289 294 (Pubitemid 32181897)
27. C. Alicea, S. Belkolski, T.K. Eisentein, M.W. Adler, and T.J. Roger Inhibition of primary murine macrophage cytokine production in vitro following treatment with κ-opioid agonist U50,488H J Neuroimmunol 64 1996 83 90
28. A.L. Parkhill, and J.M. Bidlack Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line Int Immunopharmacol 6 2006 1013 1019
29. S.C. Manolagas, and R.L. Jilka Mechanisms of disease: bone marrow, cytokines, and bone remodeling-emerging insights into the pathophysiology of osteoporosis N Engl J Med 332 1995 305 311
30. X.H. Liu, A. Kirschenbaum, S. Yao, and A.C. Levine Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-κB (RANK) ligand/RANK system Endocrinology 146 2005 1991 1998 (Pubitemid 40396909)
31. S. Kwan Tat, M. Padrines, S. Theoleyre, D. Heymann, and Y. Fortun IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology Cytokine Growth Factor Rev 15 2004 49 60
32. H. Oka, M. Miyauchi, K. Sakamoto, M. Kitagawa, K. Noguchi, and M.J. Somerman Prostaglandin E2 inhibits mineralization and enhances matrix metalloproteinase-13 in mature cementoblasts mainly via the EP4 pathway Arch Oral Biol 53 2008 243 249 (Pubitemid 351181423)
33. H. Hikiji, T. Takato, T. Shimizu, and S. Ishii The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease Prog Lipid Res 47 2008 107 126
34. P. Palmqvist, E. Persson, H.H. Conaway, and U.H. Lerner IL-6, leukemia inhibitory factor, and oncostatin M stimulate and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvarie J Immunol 169 2002 3353 3362 (Pubitemid 35013185)
35. P.K.K. Wong, J.M.W. Quinn, N.A. Sims, A. Nieuwenhuijze, I.K. Campbell, and I.P. Wicks Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis Arthritis Rheum 54 2006 158 168 (Pubitemid 43122198)
36. U.H. Lerner Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis J Dent Res 85 2006 596 607 (Pubitemid 44085948)
37. A.R. Pettit, N.C. Walsh, C. Manning, S.R. Goldring, and E.M. Gravallese RANKL protein is expressed at the panus-bone interface at sites of articular bone erosion in rheumatoid arthritis Rheumatology 45 2006 1068 1076 (Pubitemid 44542091)
38. S. Lacraz, L.P. Nicod, R. Chicheportiche, H.G. Welgus, and J.-M. Dayer IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes J Clin Invest 96 1995 2304 2311
39. M.J. Owens, C.A. Gallanger, and J.T. Chambers IL-10 modulates formation of osteoclasts in murine hemopoietic cultures J Immunol 157 1996 936 940
40. E. Gemmel, and G.J. Seymour Cytokine profiles of cells extracted from humans with periodontal diseases J Dent Res 77 1998 16 26 (Pubitemid 32770485)
41. M. Hirose, K. Ishihara, A. Saito, T. Nakagawa, S. Yamada, and K. Okuda Expression of cytokines and inducible nitric oxide synthase in inflamed gingival tissue J Periodontol 72 2001 590 597 (Pubitemid 33606325)